Watchlist Price Alert

CymaBay Therapeutics Inc. (CBAY)

NASDAQ: CBAY · Real-Time Price · USD

32.48

0.01 (0.03%)

At close: Mar 21, 2024, 8:00 PM

CymaBay Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	206.53M	20.29M	125.81M	28.19M	24.87M	48.99M	23.05M	10.49M
Short-Term Investments	187.72M	115.19M	60.73M	118.13M	166.08M	129.67M	74.16M	6.5M
Long-Term Investments	22.36M	n/a	8.07M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	2.8M	2.91M	1.72M	207K	160K	2.28M	634K	754K
Receivables	n/a	n/a	n/a	277K	687K	n/a	5M	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	1.21M	n/a
Other Current Assets	9.55M	2.59M	4.56M	4.99M	11.29M	2.9M	1.33M	1.53M
Total Current Assets	403.8M	138.07M	191.1M	151.59M	202.92M	181.56M	103.54M	18.53M
Property-Plant & Equipment	5.72M	870K	1.43M	2.03M	2.64M	2.9M	69K	77K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	30.88M	3.78M	11.22M	2.24M	2.8M	5.18M	703K	831K
Total Assets	434.69M	141.85M	202.32M	153.82M	205.73M	186.75M	104.25M	19.36M
Account Payables	3.83M	1.1M	2.73M	231K	2.5M	1.97M	1.31M	899K
Deferred Revenue	1.69M	n/a	n/a	n/a	n/a	n/a	5.8M	4.57M
Short-Term Debt	10.01M	664K	567K	482K	407K	n/a	3.11M	2.7M
Other Current Liabilities	21.32M	13.68M	15.07M	9.14M	14.73M	12.44M	11.89M	5.71M
Total Current Liabilities	36.84M	15.44M	18.37M	9.86M	17.64M	14.41M	16.31M	9.31M
Long-Term Debt	104.49M	90.26M	51.02M	1.26M	1.74M	n/a	2.99M	6.1M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	1.91M	n/a	13K
Total Long-Term Liabilities	105.59M	90.26M	51.02M	1.26M	1.74M	1.91M	2.99M	6.11M
Total Liabilities	142.43M	105.7M	69.38M	11.12M	19.38M	16.33M	19.3M	15.42M
Total Debt	114.49M	90.92M	51.58M	1.74M	2.15M	n/a	6.1M	8.8M
Common Stock	11K	8K	8K	7K	7K	6K	4K	2K
Retained Earnings	-978.23M	-872.86M	-766.86M	-676.86M	-625.87M	-523.06M	-450.52M	-422.96M
Comprehensive Income	144K	-326K	-13K	8K	80K	-58K	-44K	-1K
Shareholders Equity	292.26M	36.15M	132.94M	142.71M	186.35M	170.42M	84.95M	3.94M
Total Investments	210.08M	115.19M	68.8M	118.13M	166.08M	129.67M	74.16M	6.5M